6月4日，Oscar Health盘前上涨5.55%，报21.59美元/股，成交额197.29万美元。
消息面上，富国银行将Oscar Health评级从"跑输大盘"上调至"等权重"，目标价从11美元大幅上调至20美元。FactSet数据显示，该股当前分析师平均评级为"持有"，平均目标价为22.18美元。此前6月2日，公司首席技术官兼联合创始人Mario Schlosser卸任CTO职务转为顾问角色，曾引发市场对技术战略连续性的担忧，导致当日股价下跌逾5%。本次富国银行评级上调释放积极信号，对冲了此前CTO离任带来的负面情绪，推动股价盘前反弹。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.